Lymphangiogenesis and lung cancer.
Rouzaut
Ana
A
Oncology Division, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain. arouzaut@unav.es
Irigoyen
Marta
M
Montuenga
Luis M
LM
D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D000818:Animals; D006801:Humans; D008175:Lung Neoplasms / Q000098:blood supply / Q000378:metabolism / Q000473:pathology*; D042583:Lymphangiogenesis; D008207:Lymphatic Metastasis; D009367:Neoplasm Staging; D009389:Neovascularization, Pathologic; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D040262:Receptors, Vascular Endothelial Growth Factor / Q000378:metabolism; D042442:Vascular Endothelial Growth Factors / Q000037:antagonists & inhibitors / Q000378:metabolism*
D020533:Angiogenesis Inhibitors; D047428:Protein Kinase Inhibitors; D042442:Vascular Endothelial Growth Factors; D040262:Receptors, Vascular Endothelial Growth Factor